Document is current
Any future updates will be listed below
-
Authors
Cahill, Hannah F.
Brown, Justin M.
Leslie-Toogood, Manhattan
Venkatesh, Jaganathan
Wasson, Marie-Claire D.
Arun, Raj Pranap
McLean, Meghan E.
Vidovic, Dejan
Marcato, Paola
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (162313)
- License Information
-
More Information
Article History
Received: 1 May 2025
Accepted: 16 July 2025
First Online: 23 July 2025
Competing interests
: J.V., M.C.D.W, and P.M. are co-founders of Oncolinc Therapeutics Inc., a startup aimed at developing targeted therapies against lncRNAs as novel immunotherapies. P.M. is also a co-founder of Theranib Inc. a startup aimed at developing small molecule drugs targeting ALDH1A3 for the treatment of cancer. H.F.C., J.M.B., M.L.T.,R.P.A.,M.E.M.,and D.V have no competing interests.
